FDA approves Lyumjev™, Lilly’s new rapid-a...
The U.S. Food and Drug Administration (FDA) has approved Lyumjev™ (insulin lispro-aabc, 100 units/mL and 200 units/mL), Eli Lilly and Company’s (NYSE: LLY) new ...
Since 2004, brands have counted on Cision’s MultiVu to create and distribute their important news and marketing content to the world.
Let's talkSearch our recent client collaborations below: